New Test Detects COVID-19, Flu and Other Ailments in One Sample

European firm BioGX BV has announced a new test that detects COVID-19, Influenza A and B and other viruses in one sample.

The firm is a Netherlands-based subsidiary of BioGX, which is headquartered in Birmingham. However, the test is not available for sale or use in the U.S.

The BioGX test detects COVID-19, Influenza A and B and RSV from pharyngeal and nasopharyngeal swabs, using reagents lyophilized in a single tube in its proprietary Sample-Ready format. The test kits can be shipped globally without refrigeration.

“We are very pleased with the reliability and performance of this complex respiratory panel.  The simultaneous detection of COVID-19, Flu A, Flu B and RSV during Flu season would help further augment the BD MAX testing capacity by over 50,000 tests per week,” said Shazi Iqbal, CEO of BioGX.

- Sponsor -

The testing supplies are sold commercially by Becton, Dickinson and Company, known as BD.

Birmingham’s BioGX, parent of The Netherlands firm, is a provider of lyophilized real-time PCR reagents for molecular diagnostics in the U.S. and elsewhere.

The latest Alabama business news delivered to your inbox